Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/1424"
Predicate | Value (sorted: none) |
---|---|
rdf:type | |
rdf:type | |
rdfs:label | |
?:Evidence_type | |
?:Evidence_enzyme_system | |
dc:creator | |
dc:date |
"01/11/2010 16:56:42"
|
?:content |
"The FDA recommends sildenafil as a preferred CYP3A4/3A5 substrate for in vivo studies in it most recent guidance document (See Table 2, p. 19)"
|
rdfs:seeAlso |
All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/dikb.ttl
The resource appears as object in one triple:
{ sildenafil_primary_total_clearance_enzyme_cyp3a4, <http://purl.org/swan/1.2/swan-commons#citesAsSupportingEvidence>, evidence_1839 }